# A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

> **NCT07395986** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Age Related Cataracts

## Interventions

- **DRUG:** 0.4% ZOC2017217
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT07395986
- **Lead sponsor:** Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-10
- **Primary completion:** 2027-03
- **Final completion:** 2027-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07395986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07395986, "A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07395986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*